๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Prizvalve Transcatheter Aortic Valve in Failing Bioprosthetic Valves
NCT07122050Failing Bioprosthetic Valves
Xijing Hospital
Not applicable
140
Xi'an
2025-08-15
Not yet open
A Prospective, Open-label, Exploratory Basket Trial to Evaluate the Efficacy and Safety of Sintilimab Combined With Pyrotinib ยฑ Chemotherapy in Patients With Advanced Digestive System Tumors
NCT07053150Advanced Digestive System Tumor
Tongji Hospital
Phase 2
80
Wuhan
2025-08-15
Not yet open
Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer
NCT07139470Triple Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1/2
59
Tianjin
2025-08-15
Not yet open
Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas
NCT07129499Colorectal Adenoma, High Risk, TCM
Jiangsu Famous Medical Technology Co., Ltd.
Not applicable
450
Nanjing
2025-08-15
Not yet open
Blended Unified Protocol for Chinese Adolescents With Non-Suicidal Self-Injury: A Randomized Controlled Trial
NCT07110181Non-suicidal Self-injury (NSSI)
Jian-Jun Ou
Not applicable
60
Changsha
2025-08-15
Recruiting
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
NCT07117045Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, High-grade Pancreatic Intraepithelial Neoplasia, PDAC - Pancreatic Ductal Adenocarcinoma
Changhai Hospital
Observational
400,000
Shanghai, Jiaxing, Ningbo
2025-08-15
Recruiting
Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke
NCT07026318Acute Ischemic Stroke
Beijing Anzhen Hospital
Not applicable
716
Beijing
2025-08-15
Recruiting
Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer
NCT07095023Breast Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
112
Beijing, Guangzhou, Shantou, Nanning, Guiyang, Haikou, Wenzhou, Shenzhen
2025-08-15
Not yet open
Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma
NCT07110558Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
59
Guangzhou
2025-08-15
Recruiting
Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation
NCT07158710Malignant Brain Tumors
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
159
Beijing, Fuzhou, Guangzhou, Changchun, Shanghai
2025-08-15
Recruiting
Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma
NCT07125755Squamous Cell Cancer of Head and Neck (SCCHN)
Sun Yat-sen University
Phase 3
386
Guangzhou, Guilin, Sanya, Changsha, Nanjing
2025-08-15
Active, closed
Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial
NCT07492225Neoadjuvant Therapy, Urothelial Carcinoma Ureter, Upper Urinary Tract Urothelial Carcinoma
Changhai Hospital
Phase 2
120
Shanghai
2025-08-15
Recruiting
Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease
NCT07181525Inflamatory Bowel Disease
Peking University First Hospital
Observational
200
Beijing
2025-08-15
Not yet open
Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas
NCT07123116Colorectal Adenoma, TCM, Low Risk
Jiangsu Famous Medical Technology Co., Ltd.
Not applicable
450
Nanjing
2025-08-15
By invitation
A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data
NCT07532928Deep Learning, Head & Neck Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University
Observational
571
Guangzhou
2025-08-15
Not yet open
AI-Assisted Comprehensive Management for Cancer Patients With Comorbidities (GCOG-CG001)
NCT07136727Oncological Comorbidities (e. g. Hypertension, Diabetes, Malnutrition)
The First Affiliated Hospital of Xinxiang Medical College
Not applicable
5,000
Xinxiang
2025-08-15
By invitation
Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related Tumors
NCT07822347Tumor
Peking Union Medical College Hospital
Phase 1/2
20
Beijing
2025-08-15
Not yet open
Temporal Interference for Temporal Lobe Epilepsy Under SEEG
NCT07082101Epilepsy
Xijing Hospital
Not applicable
10
Xi'an
2025-08-15
Recruiting
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
NCT07100405Hepatocellular Carcinoma
Fudan University
Observational
50
Shanghai
2025-08-15
Not yet open
Effect of Red and Blue Light Irradiation on Wound Healing After Hemorrhoid Surgery
NCT07121686Hemorrhoids
The Affiliated Hospital of Putian University
Not applicable
315
Putian
2025-08-15
Recruiting
Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer
NCT07130240Cervical Cancers
Obstetrics & Gynecology Hospital of Fudan University
Phase 2
20
Shanghai
2025-08-15
Recruiting
A Study of SKB107 in Advanced Solid Tumors With Bone Metastases
NCT07087197Metastatic Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
90
Shanghai
2025-08-15
Recruiting
Biomarker-Integrated Digital Guidance for Early Alzheimer's Detection (BRIDGE-AD): A Nationwide Multicenter Study
NCT07284264Dementia
Xuanwu Hospital, Beijing
Observational
6,000
Beijing, Hainan, Ningxiang, Shenyang, Shenzhen, Yichun
2025-08-15
Recruiting
Clinical Application of Wearable Ultrasound Sensors
NCT07009873DVT - Deep Vein Thrombosis, POCUS
Chinese PLA General Hospital
Observational
300
Beijing
2025-08-15
Recruiting
Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users
NCT07092709Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
912
Guangzhou
2025-08-14
Recruiting
Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography
NCT07128108Chronic Liver Injury, Mindray Hepatus 9 Ultrasound Diagnostic System
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
225
Shanghai
2025-08-14
Recruiting
A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer
NCT07135544Biliary Tract Cancer, Biliary Tract Cancer (CCA)
Yongjun Chen
Phase 2
37
Wuhan
2025-08-14
Recruiting
Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
NCT07100392Hepatocellular Carcinoma (HCC)
Fudan University
Phase 2
141
Shanghai
2025-08-14
Recruiting
Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer
NCT07600268Pancreatic Cancer Non-resectable
Shandong Cancer Hospital and Institute
Phase 2
24
Jinan
2025-08-14
Recruiting
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma
NCT07023315Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Akeso
Phase 3
760
Beijing, Fuzhou, Shijiazhuang, Harbin, Shanghai, Tianjin
2025-08-14
By invitation
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
NCT07376629TNBC
Huabo Biopharm Co., Ltd.
Phase 2
60
Anyang, Changsha, Chengdu, Fujian, Guangdong, Guangzhou, Hangzhou, Harbin
2025-08-14
By invitation
Nal-IRI (ONIVYDEยฎ ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
NCT05385861GEP-NET
National Health Research Institutes, Taiwan
Phase 1/2
52
2025-08-14
Recruiting
Orelabrutinib Combined With Zebetuzumab and Lenalidomide for the Treatment of Newly Diagnosed MZL
NCT07208981Marginal Zone Lymphoma(MZL)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
169
Nanjing
2025-08-14
Active, closed
A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer
NCT07777211Advanced Pancreatic Cancer, Ductal Adenocarcinoma of Pancreas
Beijing Gene Key Life Technology Co., Ltd
Phase 1/2
52
Beijing
2025-08-14
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06948318Immune Thrombocytopenic Purpura (ITP)
Takeda
Phase 3
150
Beijing, Guangzhou, Nanning, Shijiazhuang, Wuhan, Zhengzhou, Suzhou, Nanchang
2025-08-14
Active, closed
Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD.
NCT07184697Major Depression
Ruijin Hospital
Not applicable
10
Shanghai
2025-08-14
Not yet open
Prognostic Model for MASLD Related Cirrhosis
NCT07082751Metabolic Dysfunction Associated Steatotic Liver Disease, Compensated Cirrhosis
Beijing Friendship Hospital
Observational
228
Beijing, Tianjin
2025-08-13
Active, closed
A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older
NCT07128121Respiratory Syncytial Virus (RSV) Infection
Shenzhen Shenxin Biotechnology Co., Ltd
Phase 2
500
Changsha
2025-08-13
Recruiting
Ozanimod in Patients With Alzheimer's Disease
NCT06862960Alzheimer Disease
ChenXiaoChun
Phase 2
40
Fuzhou
2025-08-13
Not yet open
Clinical Study of Trap (FAPI) 3 PET Imaging in Noninvasive Diagnosis of Malignant Tumors
NCT07128277Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Observational
10
Chongqing
2025-08-13
Recruiting
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
NCT06994650Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
140
Beijing
2025-08-13
Active, closed
Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07108699Chronic Obstructive Pulmonary Disease (COPD)
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
180
Chengdu
2025-08-13
Recruiting
ยตQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
NCT07116083Coronary Artery Disease, Coronary Artery Disease (Left Main), Obstructive Coronary Artery Disease, Stent Implantation
Shanghai Zhongshan Hospital
Observational
290
Shanghai
2025-08-13
Recruiting
The Treatment Outcomes of Cesarean Scar Pregnancy
NCT07608094Cesarean Scar Pregnancy
Women's Hospital School Of Medicine Zhejiang University
Observational
82
Hangzhou
2025-08-13
Active, closed
Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLC
NCT07703228NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC Stage IIIB~IV, Second-line Therapy, Metastases
Nanfang Hospital, Southern Medical University
Phase 2
38
Guangzhou
2025-08-13
Recruiting
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
NCT07123519Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Sjogren's Syndrome (SS), Inflammatory Myopathy
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
18
Tianjin
2025-08-13
Recruiting
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function
NCT07144098Obesity/Overweight
Gan & Lee Pharmaceuticals.
Phase 1
24
Beijing
2025-08-12
Recruiting
Clinical Performance Evaluation of a Diagnostic Ultrasound System
NCT07066449Echocardiography
GE Healthcare
Observational
60
Nanjing
2025-08-12
Active, closed
A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
NCT07100418Hyperlipidemia
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
224
Shanghai
2025-08-12
Recruiting
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
NCT07193459Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
360
Beijing
2025-08-12
Recruiting
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
NCT07132463Rectal Cancer
Fudan University
Phase 3
196
Shanghai
2025-08-12
Recruiting
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
NCT06947967Lymphoma, T-Cell, Peripheral
Chipscreen Biosciences, Ltd.
Phase 3
224
Guangzhou
2025-08-12
Recruiting
Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome
NCT06896708Chronic Coronary Syndrome
Liu yong
Not applicable
766
Chongqing, Dongguan, Guangzhou, Shenzhen, Zhongshan, Dalian
2025-08-12
Recruiting
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
NCT07070232Advanced Solid Tumor
BioNTech SE
Phase 1/2
1,438
Hangzhou, Tianjin, Wuhan
2025-08-12
Active, closed
Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)
NCT07246889Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 3
577
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Foshan, Guangzhou
2025-08-12
Active, closed
Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SYS6045 in Patients With HER2-Positive, Expressing, or Mutated Advanced Malignant Solid Tumors
NCT07122063Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1/2
266
Shenyang
2025-08-11
Active, closed
A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
NCT07021976Obstructive Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd.
Phase 3
228
Beijing
2025-08-11
Recruiting
Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma
NCT07460362MCL, Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Peking University Third Hospital
Phase 2
43
Beijing
2025-08-11
Not yet open
A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma
NCT07131501Hepatocellular Carcinoma, Immunotherapy, Preoperative, PD-1
The First Affiliated Hospital with Nanjing Medical University
Phase 2
48
Nanjing
2025-08-11
Recruiting
Nurse-supported Mobile App for Self-help CBT-I in Informal Cancer Caregivers
NCT07089797Insomnia Chronic, Cancer Caregivers
The University of Hong Kong
Not applicable
208
Shanghai
2025-08-11
Recruiting
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
NCT07032688Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
55
Chengdu
2025-08-11
Recruiting
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
NCT07126873Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia
EndoCell Therapeutics, Inc.
Phase 1/2
21
Shanghai
2025-08-11
By invitation
Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects
NCT07134465Healthy Subjects
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
24
Shanghai
2025-08-11
Recruiting
A Study of HDM2020 in Patients With Advanced Solid Tumors
NCT07098052Solid Tumor
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
60
Guangzhou
2025-08-11
Not yet open
Exploring the Efficacy of Accelerated Transcranial Direct Current Stimulation (tDCS) as Adjunct to Pharmacotherapy in the Treatment of Obsessive-compulsive Disorder
NCT07115615Obsessive Compulsive Disorder (OCD)
Shanghai Mental Health Center
Not applicable
60
Shanghai
2025-08-11
Recruiting
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
NCT07105215Solid Tumors
RemeGen Co., Ltd.
Phase 1/2
312
Beijing, Fuzhou, Xiamen, Guilin, Nanning, Harbin, Luoyan, Luoyang
2025-08-11
Recruiting
Zhongshan Ketogenic Diet Study 1
NCT07117903Platelet Function and Thrombus Formation
Fudan University
Not applicable
80
Shanghai
2025-08-10
Not yet open
High-resolution Magnetic Resonance Vessel Wall Imaging of Plaques
NCT07125339Intracranial Atherosclerotic Stenosis
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
605
Shanghai
2025-08-10
Recruiting
Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis
NCT06775782Acute Ischemic Stroke
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
1,150
Xi'an
2025-08-10
Recruiting
ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia
NCT07106684Multiple Myeloma, Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
20
Tianjin
2025-08-10
Recruiting
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
NCT07106671CRS - Cytokine Release Syndrome, Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
20
Tianjin
2025-08-10
Recruiting
Feasibility Effects of a Low-GI, High-fibre Diet in PCOS: a Prospective Cohort Study in Remote Yunnan
NCT07426146PCOS (Polycystic Ovary Syndrome)
Shanghai First Maternity and Infant Hospital
Observational
56
Gengma County, Lincang
2025-08-10
Recruiting
Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease
NCT07129642Graves Disease
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
5
Shanghai
2025-08-10
Not yet open
Multimodal Imaging Evaluation of Vulnerability of Atherosclerotic Plaques: A Comparison of HR-VWI, OCT, and RWS
NCT07133451Intracranial Atherosclerotic Stenosis
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
561
Shanghai
2025-08-10
Not yet open
A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)
NCT07112833Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital
Phase 2
36
Shijiazhuang
2025-08-10
Recruiting
ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma
NCT07106710Multiple Myeloma, Newly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
30
Tianjin
2025-08-10
Recruiting
MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma
NCT07106736Multiple Myeloma, Newly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
60
Tianjin
2025-08-10
Recruiting
Shame-Focused Cognitive Behavioral Therapy For Reducing Suicide Risk In Adolescent Psychiatric Inpatients (SF-CBT)
NCT07294001Adolescent Suicide, Suicidal Ideation, Suicidal Behavior, Shame
Peking University
Not applicable
42
Beijing
2025-08-10
Not yet open
ERP-Based Research on the Modulation of Remimazolam on Working Memory and Brain Network Mechanisms in Glioma Patients
NCT07109362Remimazolam Mild Sedation, Healthy Brain and Glioma Brain
Beijing Tiantan Hospital
Not applicable
60
Beijing
2025-08-10
Not yet open
Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting
NCT07124195Malignant Solid Tumors, Moderate to High Emetogenic Chemotherapy (MEC/HEC) Drugs
The First Affiliated Hospital of Xinxiang Medical College
Phase 3
126
Xinxiang
2025-08-10
By invitation
Study on the Persistence of Immunity Following EV71 Vaccination
NCT07144202Hand, Foot, and Mouth Disease, Hand, Foot, and Mouth Disease (HFMD)
Institute of Medical Biology, Chinese Academy of Medical Sciences
Observational
270
Guilin
2025-08-10
Not yet open
BCMA/CD3 BsAb Therapy for POEMS Syndrome
NCT07115654POEMS Syndrome
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
10
Tianjin
2025-08-10
Recruiting
Neural Mechanism of Cerebrocardiac Syndrome Following Traumatic Brain Injury
NCT06958406Traumatic Brain Injury, Cerebrocardiac Syndrome
Shanghai 6th People's Hospital
Observational
90
Shanghai
2025-08-10
Recruiting
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
NCT07239947Atopic Dermatitis
Bambusa Therapeutics
Phase 1
99
Hefei, Wuhu, Beijing, Guangzhou, Changsha, Wuxi, Zhenjiang, Nanchang
2025-08-09
Not yet open
Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight
NCT07110766Obesity &Amp; Overweight
MindRank AI Ltd
Phase 1
24
Chโ€™ang-chโ€™un
2025-08-09
Recruiting
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
NCT07152639Tuberculosis
Chengdu CoenBiotech Co., Ltd
Phase 3
1,784
Beijing, Hunan, Liuzhou, Xinxiang, Wuhan, Yichang, Chengdu
2025-08-09
Recruiting
Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
NCT07031531Premature Coronary Heart Disease
China National Center for Cardiovascular Diseases
Not applicable
4,900
Hefei, Beijing, Shenzhen, Shijiazhuang, Luoyang, Zhengzhou, Nanjing, Yangzhou
2025-08-08
Recruiting
Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
NCT07141303Acute Ischemic Stroke
Tang-Du Hospital
Phase 3
1,060
Xi'an
2025-08-08
Recruiting
Effects of Acute Sleep Deprivation on Individuals With Different APOE Genotypes
NCT07085754Sleep, Sleep Deprivation
Yuhui Qiu
Not applicable
60
Guangzhou
2025-08-08
Recruiting
Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery
NCT07147049Moderate to Severe Acute Postoperative Pain
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase 2
72
Chengdu
2025-08-08
Recruiting
China Colorectal Cancer Screening Trial 1 (C-Cost1)
NCT07090291Colorectal Cancer, Advanced Adenoma
Zhejiang University
Not applicable
60,300
Guandong, Guangdong, Hebei, Nanjing, Shanghai, Sichuan, Zhejiang
2025-08-08
Not yet open
Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation-positive
NCT07063329NSCLC (Non-small Cell Lung Cancer)
Avistone Pharmaceutical๏ผˆNingbo๏ผ‰Co., LTD.
Phase 1/2
108
Shanghai
2025-08-08
By invitation
A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease
NCT07130955Hypertension, CKD - Chronic Kidney Disease
Shanghai Golden Leaf MedTec Co. Ltd
Not applicable
236
Beijing
2025-08-08
Active, closed
A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus
NCT07055386Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals.
Phase 2
90
Beijing
2025-08-07
Recruiting
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
NCT06892093HER2-positive Breast Cancer, Diarrhea Caused by Drug, Neratinib
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
308
Guangzhou
2025-08-07
Active, closed
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
NCT07162181Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, B-cell Lymphoma
Eli Lilly and Company
Phase 2
13
Beijing, Guangzhou, Harbin, Shanghai, Tianjin, Wuhan
2025-08-07
By invitation
"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDN
NCT07273877Hypertension
Shanghai Golden Leaf MedTec Co. Ltd
Observational
1,000
Beijing
2025-08-07
Recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
NCT07094516Alzheimer's Disease
Novartis Pharmaceuticals
Phase 2
407
Hangzhou, Shanghai
2025-08-07
Recruiting
A Study of AK146D1 for Injection in Advanced Solid Tumors
NCT07067567Advanced Solid Tumors
Akeso
Phase 1
200
Guangzhou
2025-08-07
Recruiting
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
NCT07098351Adverse Event, Peritoneal Dialysis, Moderate-to-severe Pruritus, Chronic Kidney Disease-associated Itch
Guangdong Provincial People's Hospital
Not applicable
93
Guangzhou
2025-08-07
Rows per page Showing 6601–6700 of 19052
Previous 65 66 67 68 69 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china?page=67

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.